Alpha Tau Medical Ltd.

NasdaqCM:DRTS Stock Report

Market Cap: US$174.2m

Alpha Tau Medical Past Earnings Performance

Past criteria checks 0/6

Alpha Tau Medical's earnings have been declining at an average annual rate of -17.2%, while the Medical Equipment industry saw earnings growing at 13.4% annually.

Key information

-17.2%

Earnings growth rate

-0.8%

EPS growth rate

Medical Equipment Industry Growth8.9%
Revenue growth raten/a
Return on equity-34.5%
Net Marginn/a
Last Earnings Update31 Dec 2023

Recent past performance updates

No updates

Recent updates

Alpha Tau Medical (NASDAQ:DRTS) Is In A Good Position To Deliver On Growth Plans

Nov 08
Alpha Tau Medical (NASDAQ:DRTS) Is In A Good Position To Deliver On Growth Plans

Alpha Tau director gives up board seat to take up chief commercial officer role

Sep 02

Alpha Tau Medical GAAP EPS of -$0.03

Aug 25

Alpha Tau: Treating Cancer With Precision Alpha Radiation

Apr 12

Revenue & Expenses Breakdown
Beta

How Alpha Tau Medical makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

NasdaqCM:DRTS Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 230-29926
30 Sep 230-25924
30 Jun 230-231022
31 Mar 230-161022
31 Dec 220-341121
30 Sep 220-34919
30 Jun 220-36717
31 Mar 220-41514
31 Dec 210-27211
30 Sep 210-26210
30 Jun 210-24210
31 Mar 210-1928
31 Dec 200-928

Quality Earnings: DRTS is currently unprofitable.

Growing Profit Margin: DRTS is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: DRTS is unprofitable, and losses have increased over the past 5 years at a rate of 17.2% per year.

Accelerating Growth: Unable to compare DRTS's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: DRTS is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (6.3%).


Return on Equity

High ROE: DRTS has a negative Return on Equity (-34.52%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.